Tradestie Institutional Equity Comparison Engine
RKTO vs ENSC โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
ENSC Overall Edge
ENSC Captures Institutional Edge (3โ0 Pillars ยท 9โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Ensysce Biosciences, Inc. Common Stock (ENSC) driven by superior Valuation, Growth & Margin, Momentum & Technical. Fundamentally, RKTO trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus ENSC at 0.8x Forward P/E and -281.3% operating margin (-15.1% YoY). In options structure, RKTO sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against ENSC sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
ENSC
RKTO N/M vs ENSC 0.8x Fwd P/E
Growth & Margin Winner
ENSC
Op Margin N/A vs -281.3% ยท YoY N/A vs -15.1%
Momentum & Technical Winner
ENSC
1Y -82.5% vs -80.3% ยท 52W Pos 2% vs 8%
Options & Structure Winner
Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
RKTO
US Equity
RKTO
Institutional Equity
$0.30
+6.11% 1D
Market Cap
N/A
1M Return
-44.23%
1Y Return
-82.53%
Forward P/E
N/M
Unified AI Score
44.2 / 100
HOLD
Tech 45.0
Fund 42.0
Flow 50.0
Mom 55.0
ENSC
NASDAQ
Ensysce Biosciences, Inc. Common Stock
Pharmaceutical Preparations
$0.36
-0.17% 1D
Market Cap
$7.0M
1M Return
-29.55%
1Y Return
-80.33%
Forward P/E
0.8x
Unified AI Score
53.4 / 100
HOLD
Tech 50.0
Fund 62.0
Flow 50.0
Mom 60.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
RKTO -82.53%
ENSC -80.33%
Spread: +102.13 pp (ENSC Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
RKTO TTM Op. Margin: N/A
ENSC TTM Op. Margin: -281.3%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on RKTO vs ENSC. Trailing 12-month operating profitability (RKTO N/A vs ENSC -281.3%) and valuation multiples (RKTO N/M vs ENSC 0.8x Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | RKTO | ENSC | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | N/A | $7.0M | Larger Scale | ENSC |
| Trailing P/E Ratio Valuation | N/M | 0.8x | Lower Multiple | ENSC |
| Forward P/E Ratio Valuation | N/M | 0.8x | Lower Multiple | ENSC |
| Revenue Growth (YoY) Growth | N/A | -15.1% | Higher Growth | ENSC |
| Operating Margin (TTM) Profitability | N/A | -281.3% | Higher Margin | ENSC |
| Net Profit Margin Profitability | N/A | -280.5% | Higher Margin | ENSC |
| Return on Equity (ROE) Capital Efficiency | N/A | -1295.1% | Higher ROE | ENSC |
| 52-Week Range Position Momentum | 2% ($0โ$2) | 8% ($0โ$2) | Stronger Trend | ENSC |
| Beta / 30D Volatility Risk Regime | 1.16ฮฒ ยท 63% Vol | 0.98ฮฒ ยท 79% Vol | Lower Realized Risk | RKTO |
| Unified Institutional Score Composite Signal | 44.2 / 100 (HOLD) | 53.4 / 100 (HOLD) | Higher Composite | ENSC |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full RKTO vs ENSC Buy Guide
RKTO
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
ENSC
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither RKTO nor ENSC registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.